close Video Clinical study improved Alzheimer's symptoms without drugs UCSF clinical professor of medicine Dr. Dean Ornish joins ‘Fox & Friends’ to discuss his clinical study offering a better quality of life to Alzheimer's patients. Join Fox News for access to this content Plus special access to select articles and other premium content with your account - free of charge.
By entering your email and pushing continue, you are agreeing to Fox News' Terms of Use and Privacy Policy , which includes our Notice of Financial Incentive . Please enter a valid email address. By entering your email and pushing continue, you are agreeing to Fox News' Terms of Use and Privacy Policy , which includes our Notice of Financial Incentive .
Having trouble? Click here. A significant Alzheimer’s study is shedding new light on a protective gene that appears to delay the disease in those destined to develop it. Researchers from two Mass General Brigham hospitals — Mass Eye and Ear and Massachusetts General Hospital — have been studying a large extended family in Colombia with multiple members who have the Paisa mutation, which predicts an extremely high genetic risk of developing early-onset Alzheimer’s disease .
Most people with the Paisa variant develop mild cognitive impairment in their 40s, develop dementia in their 50s and die from complications of dementia in their 60s, according to a press release. ALZHEIMER’S BLOOD TEST ACHIEVES FASTER DIAGNOSES, HIGH ACCURACY AT MAYO CLINIC A.
